GIA
GPCR icon

Gladstone Institutional Advisory’s Structure Therapeutics GPCR Stock Holding History

Gladstone Institutional Advisory’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
+13,275
New +$587K 0.02% 497

Other funds holding GPCR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Gladstone Institutional Advisory's GPCR Position: Q2 2026 in Review

Gladstone Institutional Advisory opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 13,275 shares worth $712K. The stake represents 0.02% of the portfolio and ranks #497 among its holdings.

24 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Gladstone Institutional Advisory held 13,275 shares of Structure Therapeutics worth $712K as of Q2 2026.
  • Structure Therapeutics was a new Gladstone Institutional Advisory position in Q2 2026.
  • Structure Therapeutics made up 0.02% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #497 holding.
  • 24 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.